These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15994937)
1. Choline kinase is a novel oncogene that potentiates RhoA-induced carcinogenesis. Ramírez de Molina A; Gallego-Ortega D; Sarmentero J; Bañez-Coronel M; Martín-Cantalejo Y; Lacal JC Cancer Res; 2005 Jul; 65(13):5647-53. PubMed ID: 15994937 [TBL] [Abstract][Full Text] [Related]
2. RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. Patel S; Takagi KI; Suzuki J; Imaizumi A; Kimura T; Mason RM; Kamimura T; Zhang Z J Am Soc Nephrol; 2005 Jul; 16(7):1977-84. PubMed ID: 15901767 [TBL] [Abstract][Full Text] [Related]
3. c-Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA. Saníger ML; Oya R; Macías D; Domínguez JN; Aránega A; Luque F J Cell Biochem; 2006 Jun; 98(3):650-60. PubMed ID: 16440308 [TBL] [Abstract][Full Text] [Related]
4. Relationship of p21-activated kinase (PAK) and filopodia to persistence and oncogenic transformation. Heckman CA; Demuth JG; Deters D; Malwade SR; Cayer ML; Monfries C; Mamais A J Cell Physiol; 2009 Sep; 220(3):576-85. PubMed ID: 19384897 [TBL] [Abstract][Full Text] [Related]
5. Participation of small GTPases Rac1 and Cdc42Hs in myoblast transformation. Meriane M; Charrasse S; Comunale F; Méry A; Fort P; Roux P; Gauthier-Rouvière C Oncogene; 2002 Apr; 21(18):2901-7. PubMed ID: 11973651 [TBL] [Abstract][Full Text] [Related]
6. The insert region of RhoA is essential for Rho kinase activation and cellular transformation. Zong H; Kaibuchi K; Quilliam LA Mol Cell Biol; 2001 Aug; 21(16):5287-98. PubMed ID: 11463812 [TBL] [Abstract][Full Text] [Related]
7. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189 [TBL] [Abstract][Full Text] [Related]
8. While E1A can facilitate epithelial cell transformation by several dominant oncogenes, the C-terminus seems only to regulate rac and cdc42 function, but in both epithelial and fibroblastic cells. Fischer RS; Quinlan MP Virology; 2000 Apr; 269(2):404-19. PubMed ID: 10753719 [TBL] [Abstract][Full Text] [Related]
9. Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Bertotti A; Comoglio PM; Trusolino L Cancer Res; 2005 Dec; 65(23):10674-9. PubMed ID: 16322210 [TBL] [Abstract][Full Text] [Related]
10. Rac1, RhoA, and Cdc42 participate in HeLa cell invasion by group B streptococcus. Burnham CA; Shokoples SE; Tyrrell GJ FEMS Microbiol Lett; 2007 Jul; 272(1):8-14. PubMed ID: 17517067 [TBL] [Abstract][Full Text] [Related]
11. Differential regulation of cyclooxygenase 2 expression by small GTPases Ras, Rac1, and RhoA. Chang YW; Putzer K; Ren L; Kaboord B; Chance TW; Qoronfleh MW; Jakobi R J Cell Biochem; 2005 Oct; 96(2):314-29. PubMed ID: 16088958 [TBL] [Abstract][Full Text] [Related]
12. Regulation of microtubule dynamics in 3T3 fibroblasts by Rho family GTPases. Grigoriev I; Borisy G; Vorobjev I Cell Motil Cytoskeleton; 2006 Jan; 63(1):29-40. PubMed ID: 16362953 [TBL] [Abstract][Full Text] [Related]
13. Regulator of G-protein signalling 3 redirects prototypical Gi-coupled receptors from Rac1 to RhoA activation. Vogt A; Lutz S; Rümenapp U; Han L; Jakobs KH; Schmidt M; Wieland T Cell Signal; 2007 Jun; 19(6):1229-37. PubMed ID: 17300916 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis. Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936 [TBL] [Abstract][Full Text] [Related]
15. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase. Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of choline kinase as a specific cytotoxic strategy in oncogene-transformed cells. Rodríguez-González A; Ramírez de Molina A; Fernández F; Ramos MA; del Carmen Núñez M; Campos J; Lacal JC Oncogene; 2003 Dec; 22(55):8803-12. PubMed ID: 14654777 [TBL] [Abstract][Full Text] [Related]
17. Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis. Aili M; Isaksson EL; Hallberg B; Wolf-Watz H; Rosqvist R Cell Microbiol; 2006 Jun; 8(6):1020-33. PubMed ID: 16681842 [TBL] [Abstract][Full Text] [Related]
18. Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression. Ramírez de Molina A; Báñez-Coronel M; Gutiérrez R; Rodríguez-González A; Olmeda D; Megías D; Lacal JC Cancer Res; 2004 Sep; 64(18):6732-9. PubMed ID: 15374991 [TBL] [Abstract][Full Text] [Related]
19. Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Coleman ML; Densham RM; Croft DR; Olson MF Oncogene; 2006 May; 25(19):2708-16. PubMed ID: 16407839 [TBL] [Abstract][Full Text] [Related]